Glaxosmithkline Stock News

LONDON (Reuters) Unilever warned of a hit to profit margins this year as it struggles to pass on higher costs to consumers, and ruled out big acquisitions following recent investor criticism of its failed pursuit of GlaxoSmithKlines consumer health business. Consumer goods companies like Unilever are grappling with a surge in raw material, energy, Read More

Unilevers under-fire boss Alan Jope today called off his dealmaking efforts after the failure of a £50 billion pursuit of GlaxoSmithKline''s consumer healthcare brands.

LONDON (Reuters) -Unilever forecast higher sales, but lower margins, this year as it grapples with soaring inflation, and ruled out big acquisitions following recent investor criticism of its failed pursuit of GlaxoSmithKlines consumer health business.

GlaxoSmithKline plc (NYSE: GSK) Q4 2021 earnings call dated Feb. 09, 2022 Corporate Participants: Nick Stone — Head of Global Investor Relations Dame Emma Walmsley — Chief Executive Officer Luke Miels — Chief Commercial Officer Deborah […] The post GlaxoSmithKline plc (GSK) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Wednesday Market Open) No news may be good news as equity index futures are pointing to a higher open on another day of light economic announcements. There are several earnings announcements but no big companies that are likely to have far-reaching effects on the market. The higher premarket move could be an impressive follow up to yesterday’s rally. Crude oil prices and yields were lower before the market open which appears to be helping equity futures. Lower oil and yields are helping reduce investor fears as the Cboe Market Volatility Index (VIX) was 3.5% lower in premarket trading and nearing 20. Many of the earnings reports this morning are positive, starting with Toyota (NYSE: TM). The automaker reported better-than-expected earnings and revenues. TM had to cut its production targets due to the semiconductor shortage, but the stock was relatively unmoved in premarket trading.

British pharmaceutical giant GlaxoSmithKline PLC on Wednesday posted an increase in net profit and sales for the final quarter of 2021

GlaxoSmithKline (NYSE: GSK ) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Check out this: Executives Buy Around $64M Of 3 Stocks Earnings GlaxoSmithKline beat estimated earnings by … Full story available on Benzinga.com

Dublin, Feb. 09, 2022 (GLOBE NEWSWIRE) -- The "Global 3D Printed Drugs (2021-2026)" report has been added to ResearchAndMarkets.com''s offering. The Global 3D Printed Drugs Market is estimated to be USD 201. 74 Mn in 2021 and is expected to reach USD 336.89 Mn by 2026, growing at a CAGR of 10.8%. Market Dynamics 3D printed drugs are medicines designed using 3D printing technology. It is particularly useful for patients having swallowing difficulties such as children, the elderly and those ailing with Alzheimer''s disease, stroke complications, head or neck tumors and other neurological disabilities. The rise in demand for personalized drugs & rapidly soluble medication, increasing usage of 3D Printing in the medical and healthcare sector, increasing prevalence of dysphagia and rising geriatric population are some of the driving factors for the market. While restrictive government regulations relating to these drugs and the adverse effects of the 3D medication may hamper the market''s growth.

Futures, Global Markets Jump As Bond Rout Eases U.S. index futures jumped along with Asian and European markets, while the VIX declined for a fourth consecutive day, setting up Wall Street for a strong open as bond markets stabilized bringing some respite for markets whipsawed in recent weeks by concerns about tightening monetary policy. As of 730am ET, S&P emini futures rose 38 points or 0.84%, while Nasdaq futures were up 1.3% or 187 points, while Dow futures were up 0.60% or 215 points. The 10-year U.S. Treasury yield retreated from levels last seen in 2019, dropping from 1.97% at their high yesterday to 1.92%, and yields across Europe also fell after France’s central banker said markets may be getting ahead of themselves in pricing rate hikes for this year. A dollar gauge slipped and cryptos jumped. Much of today''s rally is the result of Bank of France Governor Villeroy pushing back against market pricing yesterday, which suggests that there are indeed limits to just how far central banks are willing to be pushed by traders’ expectations .

GlaxoSmithKline ADR Earnings, Revenue Beat in Q4

GlaxoSmithKline Earnings, Revenue Beat in Q4

GlaxoSmithKline Plc''s (NYSE: GSK ) turnover was £9.53 billion in Q4 , up 9% Y/Y (actual exchange rate AER), 13% (constant exchange rate CER). Pharmaceuticals sales reached £5.2 billion, up 20% AER, 25% CER, driven by growth in New & Specialty products, partly offset by a decrease in the Established Products portfolio. Sales of sotrovimab, branded Xevudy, for COVID-19 treatment stood at £828 million in Q4. Vaccines turnover decreased 10% AER, 7% CER to £1.81 billion, primarily due to lower demand for routine adult vaccination due to the … Full story available on Benzinga.com

GlaxoSmithKline Plc''s (NYSE: GSK ) turnover was £9.53 billion in Q4 , up 9% Y/Y (actual exchange rate AER), 13% (constant exchange rate CER). Pharmaceuticals sales reached £5.2 billion, up 20% AER, 25% CER, driven by growth in New & Specialty products, partly offset by a decrease in the Established Products portfolio. Sales of sotrovimab, branded Xevudy, for COVID-19 treatment stood at £828 million in Q4. Vaccines turnover decreased 10% AER, 7% CER to £1.81 billion, primarily due to lower demand for routine adult vaccination due to the … Full story available on Benzinga.com

GlaxoSmithKline (NYSE:GSK) declares GBP 0.23/share quarterly dividend, 21.1% increase from prior dividend of GBP 0.19.Forward yield 2.76%Payable April 7; for shareholders of record Feb.